This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sprint Nextel, Palm: Early Volume Plays

( Palm item updated to correct Michael Abbott's position with the company.)

NEW YORK ( TheStreet) -- Sprint Nextel (S) was set to be a volume leader among stocks trading near $5 Monday following an analyst upgrade.

Sprint shares rose 0.7% to $4.11 in the premarket trading session after Wells Fargo upgraded the stock to outperform from market perform.

In late March, Sprint unveiled the EVO 4G, which it touted as the world's first 4G smartphone.

The three-month average daily volume for Sprint is 56.99 million, according to Yahoo! Finance.

Elsewhere, Standard Pacific (SPF - Get Report) may trade lower on an increase in volume after the homebuilder reported a first-quarter loss of 2 cents a share, which surprised analysts who expected a break-even quarter.

Additionally, Standard Pacific reported revenue of $175.4 million in the first quarter, which was down 16% from a year ago and was much worse than the Thomson Reuters average estimate of $279.4 million.

Standard Pacific shares closed Friday at $5.51. The three-month average daily volume for Standard Pacific is 2.2 million.

Palm (PALM), which has traded on big swings on speculation the company is a takeover target, said in a regulatory filing that it is paying certain key employees a grant of restricted stock units and a cash bonus of $250,000.

The news of retention bonuses came as Michael Abbott, Palm's senior VP of software and sales, tendered his resignation on April 12.

Palm shares closed Friday at $5.59. The 50-day average daily volume for Palm is 31 million, according to the Nasdaq.

EntreMed (ENMD) may lose ground Monday after the pharmaceutical company said it priced a registered direct offering of roughly 5.79 million shares at 51.8 cents per share for net proceeds of $2.8 million.

EntreMed said it will use the net proceeds for further clinical development of its Aurora A/angiogenic kinase inhibitor, ENMD-2076. EntreMed recently announced the initiation of a Phase 2 study in ovarian cancer patients after encouraging Phase 1 results.

EntreMed shares closed Friday at 62 cents. The 50-day average daily volume for is 392,000.

-- Written by Robert Holmes in Boston.

Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on Twitter and become a fan of on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ENMD $1.18 1.72%
SPF $8.96 0.34%
S $4.75 0.64%
AAPL $126.37 2.53%
FB $83.20 -0.13%


DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs